Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments
Author:
Publisher
Frontiers Media SA
Subject
General Chemistry
Reference180 articles.
1. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals;Adamis;Ophthalmology,2006
2. Ligand-targeted therapeutics in anticancer therapy;Allen;Nat. Rev. Cancer,2002
3. Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer;Ando;Cancer Chemother. Pharmacol,2012
4. Magnetic nanoparticles for drug delivery;Arruebo;Nano Today,2007
5. Antibody-conjugated nanoparticles for biomedical applications;Arruebo;J. Nanomat,2009
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nano-bio fusion: Advancing biomedical applications and biosensing with functional nanomaterials;Optics & Laser Technology;2024-01
2. Lipid-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024
3. Advances in Nanotechnology for Enhanced Leukemia Therapy: A Systematic Review of In Vivo Studies;Journal of Lab Animal Research;2023-12-25
4. A di-electrophoretic simulation procedure of iron-oxide micro-particle drug attachment system for leukemia treatment using COMSOL software: a potential treatment reference for LMICs;Frontiers in Medical Technology;2023-10-12
5. Pharmaceutical and Pharmacokinetic Aspects of Nanoformulation Based Drug Delivery Systems for Anti-cancer Drugs;Current Pharmaceutical Design;2023-09-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3